Nikhil Rao from Syncell discusses how the Microscoop® optoproteomics platform enables unbiased proteomic exploration of disease-relevant sites.



Summary

Nikhil Rao of Syncell highlights the power of their Microscoop® optoproteomics platform for advancing disease research. This technology allows scientists to conduct unbiased proteomic analyses directly at disease-relevant sites within tissues or cells. By combining spatial resolution with comprehensive protein identification, Microscoop® offers unprecedented insights into the proteomic landscape of specific areas of interest. This targeted approach overcomes limitations of traditional methods, enabling researchers to identify novel biomarkers and understand the intricate molecular mechanisms driving diseases at a localized level, ultimately accelerating drug discovery and diagnostics development.

Read more…

This post is part of “Science and Technology News”, Follow for more…!!!